Serological Response to the BNT162b2 mRNA or Chadox-Ncov-19 COVID-19 Vaccine after First and Second Doses in Plasma Cell Disorder Patients: Influence of Host and Disease Factors

Background Plasma cell disorders (PCD) are at risk of inadequate immune responses to COVID-19 vaccines due to recognised humoral and cellular immune dysfunction which is multi-factorial and related to host and disease factors. With an estimated risk of 33% mortality from contracting COVID-19 in this...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Wei Yee, Howells, Lara, Wilson, William, Sanchez, Emilie, Ainley, Louise, Chavda, Selina J, Dowling, Emma, Correia, Nuno, Lecat, Catherine SY, McMillan, Annabel, Wisniowski, Brendan, Mahmood, Shameem, Papanikolaou, Xenofon, Lee, Lydia, Sive, Jonathan, Kyriakou, Charalampia, Wechalekar, Ashutosh D., Popat, Rakesh, Rabin, Neil K, Nastouli, Eleni, Yong, Kwee, Xu, Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
652.Multiple Myeloma and Plasma cell Dyscrasias: Clinical and Epidemiological
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701903/
http://dx.doi.org/10.1182/blood-2021-149027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701903/
http://dx.doi.org/10.1182/blood-2021-149027

Ejemplares similares